Evoquant LLC

EvoQuant LLC is a biotechnology company based in Chicago that specializes in AI-driven natural product drug discovery. Their proprietary platform utilizes machine learning algorithms and multi-omics data integration to predict interactions between natural compounds and biological targets. By analyzing vast amounts of microbial and biological data, the company aims to identify high-potential natural products prior to laboratory validation, effectively accelerating the discovery and development process for therapeutic candidates.

The company focuses on addressing high unmet medical needs, including cancer, rare diseases, and infectious or immune-related disorders. Their approach leverages microbial evolution to uncover novel therapeutic compounds that traditional methods might overlook, aiming to reduce the time and cost associated with drug development. EvoQuant, founded by Chase Clark, has received support for its research from the National Institutes of Health. By providing predictive insights, the company enables researchers and partners to prioritize novel therapeutics, helping to streamline the path from initial discovery to preclinical development.